An Individual Nomogram Can Reliably Predict Tumor Spread Through Air Spaces in Non-small-cell Lung Cancer
Overview
Authors
Affiliations
Background: Tumor spread through air spaces (STAS) has been shown to adversely affect the prognosis of lung cancer. The correlation between clinicopathological and genetic features and STAS remains unclear.
Method: We retrospectively reviewed 3075 NSCLC patients between2017-2019. We evaluated the relationship between STAS and patients' clinicopathological and molecular features. The chi-square test was performed to compare categorical variables. Univariate analysis and multivariate logistic regression analysis were performed to investigate the association of clinical factors with STAS. A nomogram was formulated to predict the presence of STAS.
Results: STAS was identified in 617 of 3075 patients (20.07%). STAS was significantly related to sex (p < 0.001), smoking (p < 0.001), CEA (p < 0.001), differentiation (p < 0.001), histopathological type (p < 0.001), lymphatic vessel invasion (p < 0.001), pleural invasion (p < 0.001), T stage (p < 0.001), N stage (p < 0.001), M stage (p < 0.001), and TNM stage (p < 0.001). STAS was frequently found in tumors with wild-type EGFR (p < 0.001), KRAS mutations (p < 0.001), ALK rearrangements (p < 0.001) or ROS1 rearrangements (p < 0.001). For programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1), STAS was associated with PD-L1 expression level in tumor cells (p < 0.001) or stromal cells (p < 0.001), while PD-1 only in stromal cells (p < 0.001). Multivariable analyses demonstrated significant correlations between STAS and CEA level (p < 0.001), pathological grade (p < 0.001), lymphatic vessel invasion (p < 0.001), pleural invasion (p = 0.001), and TNM stage (p = 0.002). A nomogram was formulated based on the results of the multivariable analysis.
Conclusions: Tumor STAS was associated with several invasive clinicopathological features. A nomogram was established to predict the presence of STAS in patients with NSCLC.
Xu P, Yu H, Zhao H, Bian H, Jia D, Zhi S Am J Transl Res. 2024; 16(10):6106-6118.
PMID: 39544799 PMC: 11558366. DOI: 10.62347/UJYU8551.
STAS: New explorations and challenges for thoracic surgeons.
Xia T, Yuan Q, Xing S Clin Transl Oncol. 2024; .
PMID: 39230858 DOI: 10.1007/s12094-024-03681-4.
Feng Y, Ding H, Huang X, Zhang Y, Lu M, Zhang T NPJ Precis Oncol. 2024; 8(1):173.
PMID: 39103596 PMC: 11300827. DOI: 10.1038/s41698-024-00664-0.
Liu C, Wang Y, Wang P, Guo F, Zhao H, Wang Q Oncol Lett. 2024; 27(3):122.
PMID: 38348387 PMC: 10859825. DOI: 10.3892/ol.2024.14255.
Wang J, Yao Y, Tang D, Gao W J Cardiothorac Surg. 2023; 18(1):337.
PMID: 37990253 PMC: 10664312. DOI: 10.1186/s13019-023-02458-0.